Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model

Hearing loss is the main limitation of radiation therapy for vestibular schwannoma (VS), and identifying treatment options that minimize hearing loss are urgently needed. Treatment with bevacizumab is associated with tumor control and hearing improvement in neurofibromatosis type 2 (NF2) patients; h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proc Natl Acad Sci U S A
Hauptverfasser: Gao, Xing, Zhao, Yingchao, Stemmer-Rachamimov, Anat O., Liu, Hao, Huang, Peigen, Chin, ShanMin, Selig, Martin K., Plotkin, Scott R., Jain, Rakesh K., Xu, Lei
Format: Artigo
Sprache:Inglês
Veröffentlicht: National Academy of Sciences 2015
Schlagworte:
Biological Sciences
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664377/
https://ncbi.nlm.nih.gov/pubmed/26554010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1512570112
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge